As to lymphocyte STAT1 phosphorylation in chronic RA patients not responding to multiple synthetic DMARDs, high baseline levels predicted good response to biologicals and did not decrease during the therapy. This evidence concerns the gene STAT1 and rheumatoid arthritis.